Yahoo Web Search

Search results

1. www.globenewswire.com › news-release › 2023/10/21Harpoon Therapeutics Announces Updated Interim Tolerability -...

   www.globenewswire.com › news-release › 2023/10/21

   • Cached

   Oct 21, 2023 · SOUTH SAN FRANCISCO, Calif., Oct. 21, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today...

2. www.linkedin.com › company › harpoon-therapeuticsHarpoon Therapeutics | LinkedIn

   www.linkedin.com › company › harpoon-therapeutics

   About us. Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients...

3. www.globenewswire.com › news-release › 2023/12/12Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data -...

   www.globenewswire.com › news-release › 2023/12/12

   • Cached

   Dec 12, 2023 · SOUTH SAN FRANCISCO, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today reported...